neotiv GmbH
neotiv GmbH is a German digital health company specializing in digital cognitive assessments for early detection and monitoring of Alzheimer's disease and other neurocognitive disorders.
About
neotiv GmbH is a digital health company based in Magdeburg, Germany, and a scientific spin-off of Otto-von-Guericke University Magdeburg, closely collaborating with the German Center for Neurodegenerative Diseases (DZNE). neotiv develops scientifically validated mobile apps and digital platforms that provide unique cognitive tests, facilitating early medical assessment and longitudinal tracking of memory problems, particularly in the context of Alzheimer’s disease. Its CE-marked flagship product, neotivCare, is designed for use by patients and physicians for early detection of mild cognitive impairment (MCI), supports memory assessment in routine clinical care, and is used internationally in research studies and healthcare settings. The company's mission is to translate cutting-edge neuroscience into scalable, patient-centered digital solutions for research, diagnosis, and monitoring of neurodegenerative disorders.
Products & Services
- neotivCare: CE-marked digital medical device app for early detection and assessment of mild cognitive impairment (MCI)
- Digital cognitive test battery (including scene recognition, mnemonic discrimination, and object-in-scene association and recall)
- neotiv digital platform for remote and unsupervised cognitive assessments
- neotivTrials web portal for customizable and scalable study management
- Customizable health questionnaires
- Validated cognitive testing solutions for research and clinical trials
Use Cases & Case Studies
- Early digital self-assessment for mild cognitive impairment (MCI) in primary and specialized healthcare (re.cogni.ze study)
- Digital cognitive testing in citizen science projects
- Support for clinical trials in Alzheimer's disease (including remote testing and monitoring)
- Population-based studies (H70 study, AgeCap, BioFINDER, WRAP)
- Assessment and monitoring of cognitive impairment in long COVID patients
- Diagnostic support for physicians and memory clinics in routine care
Partnerships & Collaborations
- German Center for Neurodegenerative Diseases (DZNE)
- Otto-von-Guericke University Magdeburg
- Roche Pharma AG
- Lilly Deutschland GmbH
- University of Gothenburg (H70, AgeCap)
- University of Wisconsin (WRAP study)
- Lund University (BioFINDER study)
- University College London
- RoX Health
- AD-RIDDLE (Innovative Health Initiative consortium with 24 partners including academic, government, and industry organizations)
- High-Tech Gründerfonds (HTGF)
- bmp Ventures/IBG Fonds
- Capricorn Partners
- Convergence Partners
- RSJ Investments
- Sana Kliniken AG
- Flying Health Incubator
Awards & Recognition
- 3rd place Novartis Digitaler Gesundheitspreis (Digital Health Award) 2019
- KfW Award Gründen 2018
- IQ Innovationspreis Mitteldeutschland 2018 (Silver, Life Sciences Cluster)
- IQ Innovationspreis Magdeburg 2018
Contact Information
Certifications & Compliance
- Certified quality management system according to DIN EN ISO 13485:2021 (since 2023)
- CE-marked medical device (risk class I), compliant with directive 93/42/EEC (MDD)
- Meets strict data protection requirements for digital health applications (GDPR-compliant)